Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Monfardini

Showing results (231-240 of 242) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
British Journal of Haematology|September 1, 1996
Hepatitis C virus and non-Hodgkin's lymphomasC Mazzaro, V Zagonel, S Monfardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Gynecologic Oncology|February 13, 2001
Elderly ovarian cancer: treatment with mitoxantrone-carboplatinM O Nicoletto, G Artioli, M Donach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyC Gridelli, F Perrone, C Gallo, et al.
Anti-Cancer Drugs|August 7, 2001
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J H Schellens, P Dombernowsky, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-IsoleC Gridelli, F Perrone, G P Ianniello, et al.
Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancerD Khayat, P Chollet, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
British Journal of Haematology|September 1, 1996
Hepatitis C virus and non-Hodgkin's lymphomasC Mazzaro, V Zagonel, S Monfardini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Gynecologic Oncology|February 13, 2001
Elderly ovarian cancer: treatment with mitoxantrone-carboplatinM O Nicoletto, G Artioli, M Donach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyC Gridelli, F Perrone, C Gallo, et al.
Anti-Cancer Drugs|August 7, 2001
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J H Schellens, P Dombernowsky, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-IsoleC Gridelli, F Perrone, G P Ianniello, et al.
Pageof 25